Biopharmaceutical company interrogating stem cell biology
Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.
DEF - Defense BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE PETRIZZO GROUP, INC.
601 New Jersey Ave NW, Suite 830, Washington, DC, 20001, US
TJ PETRIZZO JUSTIN LEBLANC TJ PETRIZZO JUSTIN LEBLANC TJ PETRIZZO JUSTIN LEBLANC